A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/1445744

Download in:

View as

General Info

PMID
1445744